
| 1y | 3y | 5y | 10y | |
|---|---|---|---|---|
| Total Return (%) | 5.94 | 5.08 | 3.74 | 4.66 |
| Return w/ Sales Charge (%) | 0.38 | 3.21 | 2.62 | 4.10 |
| Benchmark (%) | 4.38 | 4.77 | 2.98 | 2.08 |
| Morningstar Category Avg. (%) | 7.33 | 5.68 | 4.70 | 4.43 |
| Morningstar Ranking | 33/46 | 31/42 | 28/41 | 10/32 |
| Morningstar Quartile | 3 | 3 | 3 | 2 |
| Lipper Category Avg. (%) | 13.77 | 23.80 | 16.03 | 14.30 |
| Lipper Ranking | 35/49 | 32/45 | 31/41 | 11/29 |
| Lipper Quartile | 3 | 3 | 3 | 2 |
| YTD | 1m | 3m | 1y | 3y | 5y | 10y | |
|---|---|---|---|---|---|---|---|
| Total Return (%) | 6.54 | -0.10 | 1.12 | 5.94 | 16.03 | 20.13 | 57.69 |
| Return w/ Sales Charge (%) | 0.95 | -5.35 | -4.19 | 0.38 | 9.94 | 13.83 | 49.42 |
| Benchmark (%) | 3.17 | 0.33 | 1.08 | 4.38 | 15.00 | 15.81 | 22.92 |
| Morningstar Category Avg. (%) | 6.67 | 0.60 | 2.38 | 7.33 | 18.02 | 25.81 | 54.28 |
| Lipper Category Avg. (%) | 14.12 | 2.40 | 6.67 | 13.77 | 90.17 | 110.94 | 283.38 |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Total Return (%) | 6.03 | 1.60 | -0.25 | 5.15 | 1.95 |
| Annual w/ Sales Charge (%) | 0.47 | -3.74 | -5.49 | -0.37 | -3.40 |
| Benchmark (%) | 0.67 | 0.05 | 1.47 | 5.02 | 5.25 |
| Morningstar Category Avg. (%) | 6.69 | 4.14 | -1.75 | 5.38 | 4.14 |
Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.
On 3/1/2021 the Fund began to track the 4pm pricing variant of the ICE BofA 3-MO US Treasury Bill. Historical index data prior to 3/1/2021 is for the 3pm pricing variant of the ICE BofA 3-MO US Treasury Bill. Index data on and after 3/1/2021 is for the 4pm pricing variant of the ICE BofA 3-MO US Treasury Bill.
| Gross Expense Ratio | 1.60% |
| Net Expense Ratio | 1.51% |
Net Expense Ratio excluding Investment Related Expenses is 1.38%
| Name | Weight (%) |
|---|---|
| VERONA PHARMA PLC | 5.39 |
| CYBER ARK SOFTWARE LTD | 5.05 |
| KELLANOVA | 5.01 |
| ISHARES IBOXX HIGH YIELD CORPORATE BOND ETF | 4.37 |
| CHART INDUSTRIES INC | 4.20 |
| Name | Weight (%) |
|---|---|
| FRONTIER COMMUNICATIONS PARENT INC | 3.58 |
| SPDR BLOOMBERG BARCLAYS HIGH YIELD BOND ETF | 3.40 |
| SPECTRIS PLC | 2.58 |
| NORFOLK SOUTHERN CORPORATION | 2.57 |
| COVESTRO AG | 2.19 |
| Name | Market Value | Weight (%) | Shares |
|---|
| Issuer | Weight (%) |
|---|---|
| VERONA PHARMA PLC | 5.39 |
| CYBER ARK SOFTWARE LTD | 5.05 |
| KELLANOVA | 5.01 |
| ISHARES IBOXX HIGH YIELD CORPORATE BOND ETF | 4.37 |
| CHART INDUSTRIES INC | 4.20 |
| Issuer | Weight (%) |
|---|---|
| FRONTIER COMMUNICATIONS PARENT INC | 3.58 |
| SPDR BLOOMBERG BARCLAYS HIGH YIELD BOND ETF | 3.40 |
| SPECTRIS PLC | 2.58 |
| NORFOLK SOUTHERN CORPORATION | 2.57 |
| COVESTRO AG | 2.19 |
Mark R. McKenna, Managing Director, is Founder and Global Head of Event Driven. Mr. McKenna is responsible for managing BlackRock's event-driven investing efforts.
This fund does not seek to follow a sustainable, impact or ESG investment strategy. For more information regarding the fund's investment strategy, please see the fund's prospectus or, as applicable, shareholder report.